Xtant Medical's subsidiary, Bacterin, received a U.S. patent for "Process for Demineralization of Bone Matrix with Preservation of Natural Growth Factors."
Here are five key notes:
1. The patent covers demineralized bone matrices derived from cortical bone.
2. The technology covered in the patent is used in Bacterin's OsteoSTX, OsteoWrap and OrbitalWrap HD branded product lines.
3. The company has patent applications pending in the United States to protect other aspects of its allograft processing and demineralization techniques.
4. The patent processing technologies are designed for the allografts to expose native growth factors inherent to natural human bone. The enhanced biological activity promotes rapid healing via tissue regeneration in bone-grafting procedures.
5. Clinical investigators show Bacterin's patented demineralized bone grafts have fusion rates higher than 97 percent in peer-reviewed, published studies.